Answer
As a precaution, caplacizumab (Cablivi) should preferably be avoided during pregnancy because there are no data on its use in pregnant women.
Sources for this answer
- Cablivi 10 mg powder and solvent for solution for injectionSANOFI · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 10Document updated
Sources checked